First Time Loading...
J

Jiangsu Akcome Science & Technology Co Ltd
SZSE:002610

Watchlist Manager
Jiangsu Akcome Science & Technology Co Ltd
SZSE:002610
Watchlist
Price: 1.05 CNY -5.41% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

10.4B
-9%
Assets
Growth Rates:
1 Year
-10%
3 Years
+9%
5 Years
-27%
7 Years
-37%
10 Years
+139%
8.4B
-3%
Liabilities
Growth Rates:
1 Year
-4%
3 Years
+53%
5 Years
0%
7 Years
-23%
10 Years
+169%
2B
-29%
Equity
Growth Rates:
1 Year
-29%
3 Years
-50%
5 Years
-65%
7 Years
-64%
10 Years
+64%

Balance Sheet Decomposition
Jiangsu Akcome Science & Technology Co Ltd

10.4B
Assets
8.4B
Liabilities
10.4B
Assets
8.4B
Liabilities
Current Assets 5.1B
Cash & Short-Term Investments 97.2m
Receivables 2.9B
Other Current Assets 2.1B
Non-Current Assets 5.3B
Long-Term Investments 1.6B
PP&E 2.9B
Intangibles 206.1m
Other Non-Current Assets 560.3m
Current Liabilities 7.4B
Accounts Payable 2B
Accrued Liabilities 129.9m
Short-Term Debt 4.1B
Other Current Liabilities 1.2B
Non-Current Liabilities 968.4m
Long-Term Debt 530.3m
Other Non-Current Liabilities 438.1m

Balance Sheet
Jiangsu Akcome Science & Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1 132
2 081
2 625
713
676
326
268
330
236
97
Cash
0
0
7
0
0
0
0
330
236
97
Cash Equivalents
1 132
2 081
2 618
713
676
326
268
0
0
0
Short-Term Investments
1
0
0
3
1
0
1
0
0
0
Total Receivables
1 507
2 865
2 007
2 654
3 817
2 969
2 021
2 231
2 767
2 931
Accounts Receivables
1 255
1 774
1 613
1 899
1 789
1 741
626
546
917
1 298
Other Receivables
252
1 091
394
755
2 028
1 228
1 395
1 685
1 849
1 632
Inventory
165
295
413
256
291
241
172
427
611
422
Other Current Assets
82
47
81
2 401
1 674
1 271
2 276
1 056
2 954
1 663
Total Current Assets
2 887
5 289
5 125
6 027
6 460
4 807
4 738
4 045
6 567
5 112
PP&E Net
4 559
7 145
9 809
8 381
4 395
3 709
1 610
2 199
2 450
2 934
PP&E Gross
4 559
7 145
9 809
8 381
4 395
3 709
1 610
2 199
2 450
2 934
Accumulated Depreciation
389
680
1 086
1 264
870
1 610
416
848
777
977
Intangible Assets
198
207
264
248
202
232
164
176
204
194
Goodwill
12
12
15
8
0
0
0
12
12
12
Note Receivable
11
38
68
229
301
336
72
76
40
36
Long-Term Investments
181
201
251
1 382
2 268
1 796
2 294
2 216
1 811
1 611
Other Long-Term Assets
576
801
977
809
603
766
714
372
476
524
Other Assets
12
12
15
8
0
0
0
12
12
12
Total Assets
8 424
N/A
13 693
+63%
16 510
+21%
17 083
+3%
14 230
-17%
11 645
-18%
9 593
-18%
9 095
-5%
11 561
+27%
10 423
-10%
Liabilities
Accounts Payable
1 114
1 917
1 586
1 219
1 082
887
741
835
1 581
2 015
Accrued Liabilities
35
80
53
78
81
69
76
54
165
130
Short-Term Debt
2 880
4 548
2 647
4 551
3 708
2 937
2 290
2 585
4 772
4 458
Current Portion of Long-Term Debt
207
247
211
290
659
430
418
535
528
611
Other Current Liabilities
378
599
869
1 573
235
171
1 067
133
567
210
Total Current Liabilities
4 614
7 390
5 365
7 712
5 765
4 494
4 593
4 142
7 613
7 424
Long-Term Debt
1 209
1 871
3 346
2 652
2 296
2 623
769
911
591
530
Deferred Income Tax
0
0
0
1
8
7
7
7
7
8
Minority Interest
84
333
136
73
76
3
1
118
348
282
Other Liabilities
218
1 514
2 028
931
253
410
126
276
143
148
Total Liabilities
6 125
N/A
11 108
+81%
10 876
-2%
11 368
+5%
8 397
-26%
7 538
-10%
5 497
-27%
5 454
-1%
8 702
+60%
8 392
-4%
Equity
Common Stock
363
725
4 491
4 491
4 490
4 489
4 483
4 480
4 480
4 480
Retained Earnings
168
293
307
421
461
1 162
1 140
1 551
2 384
3 210
Additional Paid In Capital
1 767
1 568
844
861
904
794
761
746
825
822
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
4
1
1
Treasury Stock
0
0
0
50
21
13
4
30
60
60
Other Equity
1
1
8
8
2
1
4
1
0
2
Total Equity
2 299
N/A
2 585
+12%
5 634
+118%
5 715
+1%
5 832
+2%
4 107
-30%
4 096
0%
3 641
-11%
2 859
-21%
2 031
-29%
Total Liabilities & Equity
8 424
N/A
13 693
+63%
16 510
+21%
17 083
+3%
14 230
-17%
11 645
-18%
9 593
-18%
9 095
-5%
11 561
+27%
10 423
-10%
Shares Outstanding
Common Shares Outstanding
2 900
2 900
4 491
4 474
4 473
4 472
4 472
4 474
4 472
4 472

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.